The University of Chicago Header Logo

Connection

Joel Pekow to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Joel Pekow has written about Janus Kinase Inhibitors.
Joel Pekow
Connection Strength
0.365
Janus Kinase Inhibitors
  1. Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Multicenter Study. Clin Gastroenterol Hepatol. 2025 Nov; 23(12):2281-2291.e4.
    View in: PubMed
    Score: 0.220
  2. Real-World Experience with Tofacitinib in IBD at a Tertiary Center. Dig Dis Sci. 2019 07; 64(7):1945-1951.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.